• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATAMR VALVE, SMALL SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATAMR VALVE, SMALL SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Catalog Number 42955
Device Problems Inaccurate Flow Rate (1249); Appropriate Term/Code Not Available (3191)
Patient Problems Fatigue (1849); Headache (1880); Seizures (2063); Vomiting (2144); Therapeutic Response, Decreased (2271); Loss of consciousness (2418)
Event Date 11/22/2016
Event Type  Injury  
Event Description
Additional information received reported that the patient was seen on (b)(6) 2016, complaining of headaches and seizures. The doctor performed a shunt tap to assess malfunction and attempted to reprogram their shunt. Mri revealed increased ventricle size indicating underdrainage of cerebrospinal fluid. On (b)(6) 2016, the patient again presented with symptoms of underdrainage. 3 weeks prior, the patient experienced a kick to the head overlying their shunt valve with later development of headache and vomiting that progressed to prolonged seizures. Per the patient's mother, they administered midazolam and clonidine at home which aborted the seizure, but they did not return to their neurological baseline. A mri was performed in the emergency room that demonstrated overall enlargement of the bilateral ventricular system with unchanged positioning of the left parietal approach ventricular catheter. On examination, they were noted to be sleepy and unresponsive to verbal command. The patient was noted to have additional seizures in the emergency department with asymmetric appearance of their pupils. Aspiration under sterile conditions of their left parietal approach ventriculoperitoneal shunt revealed clear cerebrospinal fluid with spontaneous flow under moderate pressure, 10ml of which were removed and sent to the laboratory. The doctor recommended a shunt revision. During the revision, the doctor disconnected the ventricular catheter from the valve and found that the catheter drained spontaneously clear cerebrospinal fluid under a significant amount of pressure. The doctor proceeded to connect the manometer to the proximal end of the valve using a small piece of tubing and found no evidence of spontaneous flow through the valve and peritoneal catheter. They gently flushed through the valve and again found no evidence of flow through the manometer system into the valve and peritoneal catheter. The doctor then removed the existing valve and connected the manometer to the peritoneal catheter itself. The sterile saline then flowed into the peritoneum down to a level of -5 cm of water, consistent with a patent peritoneal catheter system and confirming the diagnosis of a valve malfunction.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The returned valve was patent. Therefore the conditions of the complaint could not be duplicated by laboratory personal. The valve met the requirements for siphon, reflux, pressure-flow, and pre-implantation testing. The valve did not meet requirements for leak testing due to a tear in the top of the reservoir. It is unknown how or when this damage occurred. The instructions for use (ifu) caution that ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting, or crushing of components. ¿ the ifu also caution that ¿care should be taken in handling the valves as silicone has a low cut and tear resistance. A review of the manufacturing records was not possible as no lot number was provided. All valves are 100% tested at the time of manufacture. A good faith effort will be made to obtain the applicable information relevant to the report. If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported to medtronic neurosurgery that the device was implanted in (b)(6) 2016. According to the report, in late (b)(6) there was no flow through the valve and there was no grossly visible deformity or debris. The valve was replaced with a new valve that worked normally and there was no injury to the patient.
 
Manufacturer Narrative
Additional information received reported the patient had underwent 4 single shot mris prior to explant. According to the report, imaging showed an enlargement of the patient¿s ventricles. It was also stated that the patient had been kicked in the head. Device information provided. Implant date provided. A review of the manufacturing records showed no anomalies.
 
Manufacturer Narrative
Additional information received reported the patient underwent two mris while the device was implanted. The valve had also been adjusted from 2. 0 to 1. 5 on (b)(6) 2016. Reportedly, the patient was ¿acute¿ prior to having the valve revised. It was also noted the valve was primed with a solution of bacitracin and saline at implant. A good faith effort will be made to obtain the applicable information relevant to the report. If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSTRATAMR VALVE, SMALL
Type of DeviceSHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
MDR Report Key6197392
MDR Text Key286557485
Report Number2021898-2016-00481
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K152700
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 06/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date04/30/2019
Device Catalogue Number42955
Device Lot NumberE13641
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2016
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received05/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-1702-2017

Patient Treatment Data
Date Received: 12/21/2016 Patient Sequence Number: 1
-
-